A NOVEL INJURY SITE-NATURAL ANTIBODY TARGETED COMPLEMENT INHIBITOR PROTECTS AGAINST LUNG TRANSPLANT AUTOANTIBODY EXACERBATED ISCHEMIA REPERFUSION INJURY. Issue 3 (September 2020)